Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 9724217, 15 pages
https://doi.org/10.1155/2017/9724217
Research Article

Quercetin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy by Inhibiting ERK/NF-κB Pathway

1Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2Department of Clinical Laboratory, Kunshan First People’s Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, China
3Department of Gastroenterology, Shanghai Tenth People’s Hospital, School of Clinical Medicine of Nanjing Medical University, Shanghai 200072, China
4Department of Gastroenterology, Jinshan Hospital of Fudan University, Jinshan, Shanghai 201508, China

Correspondence should be addressed to Xiaoming Fan and Chuanyong Guo

Received 16 March 2017; Revised 20 May 2017; Accepted 12 June 2017; Published 16 October 2017

Academic Editor: Eiji Sakai

Copyright © 2017 Liwei Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Nastos, K. Kalimeris, N. Papoutsidakis et al., “Global consequences of liver ischemia/reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 906965, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Cursio, P. Colosetti, and J. Gugenheim, “Autophagy and liver ischemia-reperfusion injury,” BioMed Research International, vol. 2015, Article ID 417590, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Casillas-Ramirez, I. B. Mosbah, F. Ramalho, J. Rosello-Catafau, and C. Peralta, “Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation,” Life Sciences, vol. 79, no. 20, pp. 1881–1894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Mehrabi, A. Mood Zh, M. Sadeghi et al., “Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation,” Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association, vol. 22, Supplement 8, pp. viii54–viii60, 2007. View at Google Scholar
  5. G. K. Glantzounis, H. J. Salacinski, W. Yang, B. R. Davidson, and A. M. Seifalian, “The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review,” Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 11, no. 9, pp. 1031–1047, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Banga, D. O. Kessel, J. V. Patel et al., “Endovascular management of arterial conduit pseudoaneurysm after liver transplantation: a report of two cases,” Transplantation, vol. 79, no. 12, pp. 1763–1765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. E. Montalvo-Jave, T. Escalante-Tattersfield, J. A. Ortega-Salgado, E. Pina, and D. A. Geller, “Factors in the pathophysiology of the liver ischemia-reperfusion injury,” The Journal of Surgical Research, vol. 147, no. 1, pp. 153–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Datta, “Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models,” World Journal of Gastroenterology, vol. 19, no. 11, p. 1683, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. A. Rüdiger and P. A. Clavien, “Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver,” Gastroenterology, vol. 122, no. 1, pp. 202–210, 2002. View at Publisher · View at Google Scholar
  10. R. Cursio, J. Gugenheim, J. E. Ricci et al., “A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis,” The FASEB Journal, vol. 13, no. 2, pp. 253–261, 1999. View at Google Scholar
  11. G. Bilbao, J. L. Contreras, D. E. Eckhoff et al., “Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene,” Annals of Surgery, vol. 230, no. 2, pp. 185–193, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Weigand, S. Brost, N. Steinebrunner, M. Buchler, P. Schemmer, and M. Muller, “Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology,” HPB Surgery, vol. 2012, Article ID 176723, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Wang, “Autophagy and apoptosis in liver injury,” Cell Cycle, vol. 14, no. 11, pp. 1631–1642, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Codogno and A. J. Meijer, “Autophagy in the liver,” Journal of Hepatology, vol. 59, no. 2, pp. 389–391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Czaja, W. X. Ding, T. M. Donohue Jr. et al., “Functions of autophagy in normal and diseased liver,” Autophagy, vol. 9, no. 8, pp. 1131–1158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. H. Baehrecke, “Autophagy: dual roles in life and death?” Nature Reviews Molecular Cell Biology, vol. 6, no. 6, pp. 505–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Klionsky, “The molecular machinery of autophagy: unanswered questions,” Journal of Cell Science, vol. 118, Part 1, pp. 7–18, 2005. View at Google Scholar
  18. J. Evankovich, R. Zhang, J. S. Cardinal et al., “Calcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 2, pp. G189–G198, 2012. View at Google Scholar
  19. J. Cardinal, P. Pan, R. Dhupar et al., “Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury,” Hepatology, vol. 50, no. 2, pp. 565–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Kim, T. Nitta, D. Mohuczy et al., “Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes,” Hepatology, vol. 47, no. 5, pp. 1725–1736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Lu, K. Dono, K. Gotoh et al., “Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation,” Archives of Histology and Cytology, vol. 68, no. 1, pp. 71–80, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Cursio, P. Colosetti, M. C. Saint-Paul et al., “Induction of different types of cell death after normothermic liver ischemia-reperfusion,” Transplantation Proceedings, vol. 42, no. 10, pp. 3977–3980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Kang, H. I. Cho, and S. M. Lee, “Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion,” Cellular Physiology and Biochemistry, vol. 33, no. 1, pp. 23–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Zou, W. Liu, B. Yang et al., “Quercetin protects against perfluorooctanoic acid-induced liver injury by attenuating oxidative stress and inflammatory response in mice,” International Immunopharmacology, vol. 28, no. 1, pp. 129–135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Liu, J. Q. Ma, W. R. Xie et al., “Quercetin protects mouse liver against nickel-induced DNA methylation and inflammation associated with the Nrf2/HO-1 and p38/STAT1/NF-kappaB pathway,” Food and Chemical Toxicology, vol. 82, pp. 19–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Trocha, “Effect of quercetin-5-sulfonic acid sodium salt on SOD activity and ADMA/DDAH pathway in extracorporeal liver perfusion in rats,” Advances in Clinical and Experimental Medicine, vol. 21, no. 4, pp. 423–431, 2012. View at Google Scholar
  27. Y. Wan, M. H. Tang, X. C. Chen, L. J. Chen, Y. Q. Wei, and Y. S. Wang, “Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A,” Brazilian Journal of Medical and Biological Research, vol. 47, no. 8, pp. 655–661, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Li, H. C. Liu, Q. Y. Yao, B. L. Xu, S. C. Zhang, and C. T. Tu, “Quercetin protects mice from ConA-induced hepatitis by inhibiting HMGB1-TLR expression and down-regulating the nuclear factor kappa B pathway,” Inflammation, vol. 39, no. 1, pp. 96–106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Y. Lin, Y. Y. Wang, W. Y. Chen, Y. H. Chuang, P. H. Pan, and C. J. Chen, “Beneficial effect of quercetin on cholestatic liver injury,” The Journal of Nutritional Biochemistry, vol. 25, no. 11, pp. 1183–1195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Wang, Y.-Y. Zhang, J. Cheng, J.-L. Zhang, and B.-S. Li, “Preventive and therapeutic effects of quercetin on experimental radiation induced lung injury in mice,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 7, pp. 2909–2914, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Q. Zhang, L. Shi, X. N. Xu et al., “Therapeutic detoxification of quercetin against carbon tetrachloride-induced acute liver injury in mice and its mechanism,” Journal of Zhejiang University Science B, vol. 15, no. 12, pp. 1039–1047, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-Y. Zhen, “Effect of different doses of quercetin on pancreatic pathology in rats with hypertriglyceridemia related acute pancreatitis,” World Chinese Journal of Digestology, vol. 23, no. 20, p. 3195, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Li, M. Yang, J. W. Liu, and G. T. Yin, “Protective mechanism of quercetin on acute myocardial infarction in rats,” Genetics and Molecular Research: GMR, vol. 15, no. 1, article 15017117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Arikan, I. Ersan, T. Karaca et al., “Quercetin protects the retina by reducing apoptosis due to ischemia-reperfusion injury in a rat model,” Arquivos Brasileiros de Oftalmologia, vol. 78, no. 2, pp. 100–104, 2015. View at Publisher · View at Google Scholar
  35. A. Ghosh, S. Sarkar, A. K. Mandal, and N. Das, “Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats,” PLoS One, vol. 8, no. 4, article e57735, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Cooper and T. Hunter, “Major substrate for growth factor-activated protein-tyrosine kinases is a low-abundance protein,” Molecular and Cellular Biology, vol. 5, no. 11, pp. 3304–3309, 1985. View at Publisher · View at Google Scholar
  37. S. Torii, “Regulatory mechanisms and function of ERK MAP kinases,” Journal of Biochemistry, vol. 136, no. 5, pp. 557–561, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. P. P. Roux and J. Blenis, “ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions,” Microbiology and Molecular Biology Reviews: MMBR, vol. 68, no. 2, pp. 320–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. C. Sun, J. H. Chang, and J. Jin, “Regulation of nuclear factor-kappaB in autoimmunity,” Trends in Immunology, vol. 34, no. 6, pp. 282–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Chi, M. Wei, X. Xie, L. W. Soromou, F. Liu, and S. Zhao, “Suppression of MAPK and NF-kappaB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury,” Inflammation, vol. 36, no. 2, pp. 501–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Zhang, J. Xia, Y. Zhang et al., “HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway,” American Journal of Translational Research, vol. 10, pp. 4054–4067, 2016. View at Google Scholar
  42. W. H. Liu, H. B. Liu, D. K. Gao et al., “ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway,” Cell Transplantation, vol. 22, no. 10, pp. 1859–1868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Cheng, F. Wang, K. Chen et al., “Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways,” Mediators of Inflammation, vol. 2014, Article ID 935251, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Wang, K. Chen, Y. Xia et al., “N-Acetylcysteine attenuates ischemia-reperfusion induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway,” PLoS One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Shen, J. Lu, W. Dai et al., “Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy,” Mediators of Inflammation, vol. 2013, Article ID 461536, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Li, F. Wang, Y. Xia et al., “Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice,” Marine Drugs, vol. 13, no. 6, pp. 3368–3387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. E. J. Choi and G. H. Kim, “Quercetin accumulation by chronic administration causes the caspase-3 activation in liver and brain of mice,” BioFactors, vol. 36, no. 3, pp. 216–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Cagnol and J. C. Chambard, “ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence,” The FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. L. O. Murphy and J. Blenis, “MAPK signal specificity: the right place at the right time,” Trends in Biochemical Sciences, vol. 31, no. 5, pp. 268–275, 2006. View at Publisher · View at Google Scholar
  50. J. W. Ramos, “The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells,” The International Journal of Biochemistry & Cell Biology, vol. 40, no. 12, pp. 2707–2719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. F. C. Liu, H. C. Lee, C. C. Liao, A. H. Li, and H. P. Yu, “Tropisetron protects against acetaminophen-induced liver injury via suppressing hepatic oxidative stress and modulating the activation of JNK/ERK MAPK pathways,” BioMed Research International, vol. 2016, Article ID 1952947, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Liu, P. Wang, M. Cong et al., “Matrix metalloproteinase-1 induction by diethyldithiocarbamate is regulated via Akt and ERK/miR222/ETS-1 pathways in hepatic stellate cells,” Bioscience Reports, vol. 36, no. 4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Gao, P. Zhou, X. Ma et al., “Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro,” PLoS One, vol. 9, no. 11, article e112698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. S. T. Chien, M. D. Shi, Y. C. Lee, C. C. Te, and Y. W. Shih, “Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells,” Cancer Cell International, vol. 15, p. 15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Jiao, B. Feng, Y. Li, Q. He, and H. Xu, “Hepatic ERK activity plays a role in energy metabolism,” Molecular and Cellular Endocrinology, vol. 375, no. 1-2, pp. 157–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. N. A. Kretzmann, E. Chiela, U. Matte, N. Marroni, and C. A. Marroni, “N-acetylcysteine improves antitumoural response of interferon alpha by NF-kB downregulation in liver cancer cells,” Comparative Hepatology, vol. 11, no. 1, p. 4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Y. Jiang, Y. Y. Zou, and J. T. Wang, “p38 mitogen-activated protein kinase-induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for neuroprotection in retinal ischemia/reperfusion injury,” Molecular Vision, vol. 18, pp. 2096–2106, 2012. View at Google Scholar